1. Genentech: CAPSTONE-2 trial with Baloxavir Marboxil for Flu Meets primary target Nasdaq
  2. Roche wins test victory for the antiviral anti-virus drug Reuters
  3. Full coverage

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.